QuidelOrtho Corp (QDEL): רווח נקי למניה (EPS TTM)

The profit per share trend over the last 12 months reflects the asset's dynamics, where the metric value stands at -5.36. QuidelOrtho (QDEL) management is currently focusing on extracting merger synergies and updating its test portfolio. Revenues are based on the sale of high-cost reagents and seasonal demand. Traditional laboratory tests provide a stable cash flow, supporting the business's operational resilience.

Investors are verifying the issuer's financial stability by analyzing its ability to generate real earnings per share. The current level of rolling earnings per share reflects the final annual net income adjusted for capital dilution, which for QuidelOrtho (QDEL) confirms the cost efficiency of complex temperature-controlled reagent logistics and the overall operating margins of the business.